Storia in 3 fonti

AstraZeneca picks up FDA approval for hypertension drug

The China question, FDA leadership shakeups, and other biotech news from The Readout

Raccontata da

endpoints.news

fiercepharma.com

statnews.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 mesi fa

AstraZeneca picks up FDA approval for hypertension drug

The China question, FDA leadership shakeups, and other biotech news from The Readout

originale

endpoints.news1 mesi fa

AstraZeneca's blood pressure pill approved, but competition could be around the corner

One of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said Monday.

Leggi questa versione → originale

Timeline cronologica

lunedì 18 maggio 2026·endpoints.news
AstraZeneca's blood pressure pill approved, but competition could be around the corner
One of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said Monday.
lunedì 18 maggio 2026·fiercepharma.com
AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone synthase inhibitor (ASI) baxdrostat has continued to pay off. | After an…

AstraZeneca picks up FDA approval for hypertension drug

AstraZeneca's blood pressure pill approved, but competition could be around the corner

Timeline cronologica

AstraZeneca's blood pressure pill approved, but competition could be around the corner

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too

AstraZeneca picks up FDA approval for hypertension drug

Drugmakers guard IP more tightly amid China competition